Moderna is focused exclusively on advancing messenger RNA (mRNA) medicines. Using mRNA – a fundamental component of human biology – as a drug, our medicines are sets of instructions that direct cells in the body to make proteins to prevent or fight disease.
This approach represents an entirely new drug class, and the chance to treat and prevent diseases that aren’t druggable with small molecule drugs or biologics. Additionally, the inherent softwarelike, digital nature of mRNA technology presents the opportunity to build a completely novel type of biopharmaceutical company specifically tailored to explore and exploit the potential of mRNA science to treat human diseases.
For more details, download White Paper here:
Building The Digital Biotech Company
Only registered and logged in users can download this file.